02 Feb 2026 NDAT.CN stock down 50% to C$0.02 on CNQ: liquidity concerns rise

On 02 Feb 2026 the NDAT.CN stock plunged 50.00% to C$0.02 during Canada market hours on the CNQ exchange. We saw high turnover with 15,000 shares traded versus an average of 4,903. The drop followed heavy selling from the open price of C$0.03 and a previous close of C$0.04. This intraday move raises short-term liquidity and valuation questions for nDatalyze Corp.

NDAT.CN stock market move and immediate drivers

The stock moved from C$0.03 open to a low of C$0.02 on CNQ, a 50.00% decline. One clear driver was low float and thin trading that amplified selling pressure. We link observed price action to thin liquidity and limited public news flow, per available market feeds.

Company fundamentals and key ratios

nDatalyze Corp. (NDAT.CN) lists on CNQ in Canada with a market cap of C$1,033,185.00 and 41,327,400 shares outstanding. Key metrics include EPS -0.02, PE -1.25, and PB 2.06. The company shows cash per share C$0.01 and book value per share C$0.01, highlighting tiny absolute balances versus market moves.

Trading liquidity, averages and volatility

Volume spiked to 15,000 versus an average volume of 4,903, giving a relative volume of 10.20. The 50-day average price is C$0.02 and the 200-day average price is C$0.02. Thin trading elevates volatility and can produce sharp intraday swings for small-cap Healthcare names like NDAT.CN.

Meyka grade and technical perspective

Meyka AI rates NDAT.CN with a score out of 100: 58.45 | Grade C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technical indicators are limited due to low liquidity, so trend signals remain unreliable for active trading decisions.

Price targets, Meyka forecast and scenarios

Meyka AI’s forecast model projects a 12-month base case target of C$0.03, implying +50.00% upside from C$0.02. A downside scenario target is C$0.01, implying -50.00%. Forecasts are model-based projections and not guarantees. We advise weighting these targets by liquidity risk and the company’s negative earnings profile.

Risks, sector context and opportunities

NDAT.CN operates in Healthcare information services and also sells extraction equipment. Sector peers show stronger margins and larger market caps, increasing relative risk. Key risks include prolonged losses, thin liquidity and low revenue per share. Opportunities center on any credible progress with the machine-learning mental health product or licensing deals that boost revenue visibility.

Final Thoughts

NDAT.CN stock’s 50.00% intraday fall to C$0.02 on 02 Feb 2026 highlights the risks of trading low-float Healthcare microcaps on CNQ. Fundamentals show EPS -0.02 and PE -1.25, while cash and book values are tiny in absolute terms. Meyka AI rates NDAT.CN C+ (58.45) with a HOLD view, reflecting weak financial growth but limited downside from extremely low market cap. Meyka AI’s forecast model projects a base case price target C$0.03 over 12 months, an implied +50.00% upside versus the current price, and a downside case C$0.01 (-50.00%). These forecasts are model-based projections and not guarantees. Traders should treat NDAT.CN as speculative, factor in sector comparatives, and size risk accordingly. For more details, see our live stock page and the market note linked below for trade context.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.